Related Experiment Video
Updated: May 22, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Blocking FSH action attenuates osteoclastogenesis
Ling-Ling Zhu1, Irina Tourkova, Tony Yuen
1School of Stomatology, Wuhan University, Wuhan, China.
Abstract:
A direct effect of FSH on bone turnover via stimulation of osteoclast formation has been reported. Here we show that monoclonal or polyclonal antibodies to FSH inhibit osteoclast formation induced by FSH to an extent similar to that noted in FSH receptor (FSHR) knockout cells. Furthermore, we document the amplification of FSHR cDNA from well-characterized human CD14+ osteoclast precursors and osteoclasts, and the direct sequencing of the PCR products to definitively establish the expression of FSHRs. At these sites, the FSHR was expressed predominantly as an isoform that omits exon 9, a linker between the FSH-binding region and a long, invariant signaling domain of the receptor. These data provide compelling evidence for expression of a FSH receptor isoform in osteoclasts and their precursors.
Insights
Follicle-stimulating hormone (FSH) directly impacts bone turnover by stimulating osteoclast formation. This study confirms FSH receptor (FSHR) expression in osteoclasts, revealing a specific isoform involved in this process.
Area of Science:
- Endocrinology
- Bone Biology
- Cell Biology
Background:
- Follicle-stimulating hormone (FSH) has been implicated in bone turnover through osteoclast formation.
- The precise mechanism and receptor involvement in osteoclasts remain under investigation.
Purpose of the Study:
- To investigate the direct role of FSH and its receptor (FSHR) in osteoclast formation and function.
- To identify and characterize the expression of FSHR in human osteoclast precursors and mature osteoclasts.
Main Methods:
- Utilized monoclonal and polyclonal antibodies against FSH to inhibit FSH-induced osteoclast formation.
- Generated FSH receptor (FSHR) knockout cells for comparative analysis.
- Amplified FSHR cDNA from human CD14+ osteoclast precursors and osteoclasts.
- Performed direct sequencing of PCR products to confirm FSHR expression and identify isoforms.
Main Results:
- Antibodies targeting FSH significantly inhibited FSH-induced osteoclast formation, comparable to FSHR knockout cells.
- Confirmed the expression of FSHR cDNA in human osteoclast precursors and osteoclasts.
- Identified a predominant FSHR isoform lacking exon 9 in these cells, suggesting a distinct signaling pathway.
Conclusions:
- These findings provide strong evidence for the expression of a specific FSH receptor isoform in osteoclasts and their precursors.
- This supports a direct role for FSH signaling in regulating bone turnover via osteoclast modulation.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Skeleton and Calcium Homeostasis
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
